Skip to main content

Published works by Kelly Kearney

LEX-AR-84T3F5HA · complete body of work · page 1 of 1 · 14 works

Published works

FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B
Health Industry Washington Watch · April 2, 2024
LEX-WK-9YCNS1HC
FDA and DEA seek to ameliorate the shortage and misuse of stimulants
Health Industry Washington Watch · August 4, 2023
LEX-WK-WRNK7GYG
OIG approves arrangement involving a testamentary gift to a nonprofit hospital to reduce costs for pediatric patients
Health Industry Washington Watch · February 23, 2022
LEX-WK-E92101MY
CMS acknowledges improvement in nursing home COVID-19 response, eliminates certain blanket waivers
Health Industry Washington Watch · April 29, 2021
LEX-WK-VTE79YV8
Open for business in 2021
Health Industry Washington Watch · December 11, 2020
LEX-WK-HYGD1DFW
CMS releases roadmap for states to accelerate adoption of value-based care
Health Industry Washington Watch · September 18, 2020
LEX-WK-M4EKXQ9W
Reliance on telehealth ramps up during COVID-19, and may be here to stay
Health Industry Washington Watch · June 25, 2020
LEX-WK-PCTRTTBW
FDA publishes new draft guidance on animal drug compounding
Life Sciences Legal Update · November 25, 2019
LEX-WK-9XMAHBY6
The Drug Enforcement Administration amends regulations applicable to registrants ordering certain controlled substances
Life Sciences Legal Update · October 24, 2019
LEX-WK-JYVFGGTQ
FDA Partners with the National Association of Boards of Pharmacy to Create an Information-Sharing System for Drug Compounding Activities
Life Sciences Legal Update · October 7, 2019
LEX-WK-J0NQFA7J
Outsourcing Facility Athenex Withdraws Appeal of District Court’s Ruling on FDA’s Placement of Bulk Drug Substances on its “Clinical Need” List
Life Sciences Legal Update · September 27, 2019
LEX-WK-35WZEFKH
Recent Traction In FDA’s Development of the 503A and 503B Bulks Lists
Life Sciences Legal Update · September 9, 2019
LEX-WK-18HYWW6D
FDA Issues 2019 Goals to Improve The Quality of Compounded Drugs
Life Sciences Legal Update · April 9, 2019
LEX-WK-BSF8YHN3
To close out 2018, FDA published a revised draft guidance on human drug compounding for outsourcing facilities
Life Sciences Legal Update · January 29, 2019
LEX-WK-39WM0N9E